Trial Profile
An Open-Label Extension Study to Evaluate the Safety and Efficacy of BG9924 When Given in Combination With Methotrexate to Subjects With Rheumatoid Arthritis Who Previously Participated in Study 104RA203.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Jan 2016
Price :
$35
*
At a glance
- Drugs Baminercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Biogen
- 17 Jun 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 16 Oct 2008 Actual patient number (72) added as reported by ClinicalTrials.gov.
- 16 Oct 2008 Status changed from recruiting to discontinued as reportede by ClinicalTrials.gov.